-
Je něco špatně v tomto záznamu ?
Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions
M. Holeček,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
ProQuest Central
od 2010-09-01
Open Access Digital Library
od 2010-09-01
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
Health & Medicine (ProQuest)
od 2010-09-01
Wiley-Blackwell Open Access Titles
od 2010
ROAD: Directory of Open Access Scholarly Resources
od 2010
PubMed
28493406
DOI
10.1002/jcsm.12208
Knihovny.cz E-zdroje
- MeSH
- kachexie dietoterapie patofyziologie MeSH
- kosterní svaly účinky léků fyziologie MeSH
- lidé MeSH
- potravní doplňky MeSH
- sarkopenie dietoterapie patofyziologie MeSH
- svalová atrofie dietoterapie patofyziologie MeSH
- svalová síla účinky léků MeSH
- syndrom chřadnutí dietoterapie patofyziologie MeSH
- valeráty aplikace a dávkování farmakologie MeSH
- zdraví MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Beta-hydroxy-beta-methylbutyrate (HMB) is a metabolite of the essential amino acid leucine that has been reported to have anabolic effects on protein metabolism. The aims of this article were to summarize the results of studies of the effects of HMB on skeletal muscle and to examine the evidence for the rationale to use HMB as a nutritional supplement to exert beneficial effects on muscle mass and function in various conditions of health and disease. The data presented here indicate that the beneficial effects of HMB have been well characterized in strength-power and endurance exercise. HMB attenuates exercise-induced muscle damage and enhances muscle hypertrophy and strength, aerobic performance, resistance to fatigue, and regenerative capacity. HMB is particularly effective in untrained individuals who are exposed to strenuous exercise and in trained individuals who are exposed to periods of high physical stress. The low effectiveness of HMB in strength-trained athletes could be due to the suppression of the proteolysis that is induced by the adaptation to training, which may blunt the effects of HMB. Studies performed with older people have demonstrated that HMB can attenuate the development of sarcopenia in elderly subjects and that the optimal effects of HMB on muscle growth and strength occur when it is combined with exercise. Studies performed under in vitro conditions and in various animal models suggest that HMB may be effective in treatment of muscle wasting in various forms of cachexia. However, there are few clinical reports of the effects of HMB on muscle wasting in cachexia; in addition, most of these studies evaluated the therapeutic potential of combinations of various agents. Therefore, it has not been possible to determine whether HMB was effective or if there was a synergistic effect. Although most of the endogenous HMB is produced in the liver, there are no reports regarding the levels and the effects of HMB supplementation in subjects with liver disease. Several studies have suggested that anabolic effects of HMB supplementation on skeletal muscle do not occur in healthy, non-exercising subjects. It is concluded that (i) HMB may be applied to enhance increases in the mass and strength of skeletal muscles in subjects who exercise and in the elderly and (ii) studies examining the effects of HMB administered alone are needed to obtain conclusions regarding the specific effectiveness in attenuating muscle wasting in various muscle-wasting disorders.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010579
- 003
- CZ-PrNML
- 005
- 20180426142843.0
- 007
- ta
- 008
- 180404s2017 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jcsm.12208 $2 doi
- 035 __
- $a (PubMed)28493406
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Holeček, Milan $u Department of Physiology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
- 245 10
- $a Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions / $c M. Holeček,
- 520 9_
- $a Beta-hydroxy-beta-methylbutyrate (HMB) is a metabolite of the essential amino acid leucine that has been reported to have anabolic effects on protein metabolism. The aims of this article were to summarize the results of studies of the effects of HMB on skeletal muscle and to examine the evidence for the rationale to use HMB as a nutritional supplement to exert beneficial effects on muscle mass and function in various conditions of health and disease. The data presented here indicate that the beneficial effects of HMB have been well characterized in strength-power and endurance exercise. HMB attenuates exercise-induced muscle damage and enhances muscle hypertrophy and strength, aerobic performance, resistance to fatigue, and regenerative capacity. HMB is particularly effective in untrained individuals who are exposed to strenuous exercise and in trained individuals who are exposed to periods of high physical stress. The low effectiveness of HMB in strength-trained athletes could be due to the suppression of the proteolysis that is induced by the adaptation to training, which may blunt the effects of HMB. Studies performed with older people have demonstrated that HMB can attenuate the development of sarcopenia in elderly subjects and that the optimal effects of HMB on muscle growth and strength occur when it is combined with exercise. Studies performed under in vitro conditions and in various animal models suggest that HMB may be effective in treatment of muscle wasting in various forms of cachexia. However, there are few clinical reports of the effects of HMB on muscle wasting in cachexia; in addition, most of these studies evaluated the therapeutic potential of combinations of various agents. Therefore, it has not been possible to determine whether HMB was effective or if there was a synergistic effect. Although most of the endogenous HMB is produced in the liver, there are no reports regarding the levels and the effects of HMB supplementation in subjects with liver disease. Several studies have suggested that anabolic effects of HMB supplementation on skeletal muscle do not occur in healthy, non-exercising subjects. It is concluded that (i) HMB may be applied to enhance increases in the mass and strength of skeletal muscles in subjects who exercise and in the elderly and (ii) studies examining the effects of HMB administered alone are needed to obtain conclusions regarding the specific effectiveness in attenuating muscle wasting in various muscle-wasting disorders.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kachexie $x dietoterapie $x patofyziologie $7 D002100
- 650 _2
- $a potravní doplňky $7 D019587
- 650 _2
- $a zdraví $7 D006262
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a svalová síla $x účinky léků $7 D053580
- 650 _2
- $a kosterní svaly $x účinky léků $x fyziologie $7 D018482
- 650 _2
- $a svalová atrofie $x dietoterapie $x patofyziologie $7 D009133
- 650 _2
- $a sarkopenie $x dietoterapie $x patofyziologie $7 D055948
- 650 _2
- $a valeráty $x aplikace a dávkování $x farmakologie $7 D014631
- 650 _2
- $a syndrom chřadnutí $x dietoterapie $x patofyziologie $7 D019282
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 773 0_
- $w MED00195035 $t Journal of cachexia, sarcopenia and muscle $x 2190-6009 $g Roč. 8, č. 4 (2017), s. 529-541
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28493406 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180426142954 $b ABA008
- 999 __
- $a ok $b bmc $g 1288064 $s 1007391
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 8 $c 4 $d 529-541 $e 20170510 $i 2190-6009 $m Journal of cachexia, sarcopenia and muscle $n J Cachexia Sarcopenia Muscle $x MED00195035
- LZP __
- $a Pubmed-20180404